טוען...
Anti-IgE: A treatment option in allergic rhinitis?
Background: Allergic rhinitis (AR) is the most common IgE-mediated allergic disease. Multiple clinical trials have demonstrated promising results on the AR treatment with biologics, in particular with the use of omalizumab – an anti-IgE antibody. Omalizumab has also been established in the routine m...
שמור ב:
| הוצא לאור ב: | Allergol Select |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Dustri-Verlag Dr. Karl Feistle
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7905705/ https://ncbi.nlm.nih.gov/pubmed/33644635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/ALX02205E |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|